These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

811 related articles for article (PubMed ID: 21302010)

  • 21. gPKPDSim: a SimBiology
    Hosseini I; Gajjala A; Bumbaca Yadav D; Sukumaran S; Ramanujan S; Paxson R; Gadkar K
    J Pharmacokinet Pharmacodyn; 2018 Apr; 45(2):259-275. PubMed ID: 29302838
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of robust criteria for D-optimal designs.
    Foo LK; McGree J; Eccleston J; Duffull S
    J Biopharm Stat; 2012; 22(6):1193-205. PubMed ID: 23075017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of graphical diagnostics for assessing goodness of fit of logistic regression models.
    Pavan Kumar VV; Duffull SB
    J Pharmacokinet Pharmacodyn; 2011 Apr; 38(2):205-22. PubMed ID: 21153868
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adjusted adaptive Lasso for covariate model-building in nonlinear mixed-effect pharmacokinetic models.
    Haem E; Harling K; Ayatollahi SM; Zare N; Karlsson MO
    J Pharmacokinet Pharmacodyn; 2017 Feb; 44(1):55-66. PubMed ID: 28144841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Methods of robust design of nonlinear models with an application to pharmacokinetics.
    Foo LK; Duffull S
    J Biopharm Stat; 2010 Jul; 20(4):886-902. PubMed ID: 20496212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantifying the Effectiveness of Dose Individualization by Simulation for a Drug With Moderate Pharmacokinetic Variability.
    Liefaard L; Chen C
    Ther Drug Monit; 2015 Oct; 37(5):641-8. PubMed ID: 26378372
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 4: prediction of plasma concentration-time profiles in human from in vivo preclinical data by using the Wajima approach.
    Vuppugalla R; Marathe P; He H; Jones RD; Yates JW; Jones HM; Gibson CR; Chien JY; Ring BJ; Adkison KK; Ku MS; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4111-26. PubMed ID: 21480234
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Methods and software tools for design evaluation in population pharmacokinetics-pharmacodynamics studies.
    Nyberg J; Bazzoli C; Ogungbenro K; Aliev A; Leonov S; Duffull S; Hooker AC; Mentré F
    Br J Clin Pharmacol; 2015 Jan; 79(1):6-17. PubMed ID: 24548174
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multivariate Exact Discrepancy: A New Tool for PK/PD Model Evaluation.
    Baklouti S; Comets E; Gandia P; Concordet D
    Clin Pharmacokinet; 2023 Nov; 62(11):1599-1609. PubMed ID: 37717242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Limited sampling models and Bayesian estimation for mycophenolic acid area under the curve prediction in stable renal transplant patients co-medicated with ciclosporin or sirolimus.
    Musuamba FT; Rousseau A; Bosmans JL; Senessael JJ; Cumps J; Marquet P; Wallemacq P; Verbeeck RK
    Clin Pharmacokinet; 2009; 48(11):745-58. PubMed ID: 19817503
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Application of a hazard-based visual predictive check to evaluate parametric hazard models.
    Huh Y; Hutmacher MM
    J Pharmacokinet Pharmacodyn; 2016 Feb; 43(1):57-71. PubMed ID: 26563504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systematic external evaluation of published population pharmacokinetic models of mycophenolate mofetil in adult kidney transplant recipients co-administered with tacrolimus.
    Zhang HX; Sheng CC; Liu LS; Luo B; Fu Q; Zhao Q; Li J; Liu YF; Deng RH; Jiao Z; Wang CX
    Br J Clin Pharmacol; 2019 Apr; 85(4):746-761. PubMed ID: 30597603
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nonlinear mixed-effects models for pharmacokinetic data analysis: assessment of the random-effects distribution.
    Drikvandi R
    J Pharmacokinet Pharmacodyn; 2017 Jun; 44(3):223-232. PubMed ID: 28194555
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Quantitative Clinical Pharmacology in Pediatric Approval and Labeling.
    Mehrotra N; Bhattaram A; Earp JC; Florian J; Krudys K; Lee JE; Lee JY; Liu J; Mulugeta Y; Yu J; Zhao P; Sinha V
    Drug Metab Dispos; 2016 Jul; 44(7):924-33. PubMed ID: 27079249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Development and evaluation of the population pharmacokinetic models for FVIII and FIX concentrates of the WAPPS-Hemo project.
    Hajducek DM; Chelle P; Hermans C; Iorio A; McEneny-King A; Yu J; Edginton A
    Haemophilia; 2020 May; 26(3):384-400. PubMed ID: 32281726
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of nonlinear mixed effects modelling in the development of in vitro-in vivo correlations.
    Bigora S; Piscitelli D; Dowell J; Butler J; Farrell C; Devane J; Young D
    Adv Exp Med Biol; 1997; 423():207-15. PubMed ID: 9269497
    [No Abstract]   [Full Text] [Related]  

  • 37. PhRMA CPCDC initiative on predictive models of human pharmacokinetics, part 2: comparative assessment of prediction methods of human volume of distribution.
    Jones RD; Jones HM; Rowland M; Gibson CR; Yates JW; Chien JY; Ring BJ; Adkison KK; Ku MS; He H; Vuppugalla R; Marathe P; Fischer V; Dutta S; Sinha VK; Björnsson T; Lavé T; Poulin P
    J Pharm Sci; 2011 Oct; 100(10):4074-89. PubMed ID: 21452299
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Designs for population pharmacodynamics: value of pharmacokinetic data and population analysis.
    Hashimoto Y; Sheiner LB
    J Pharmacokinet Biopharm; 1991 Jun; 19(3):333-53. PubMed ID: 1875286
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population pharmacokinetic evaluation with external validation and Bayesian estimator of voriconazole in liver transplant recipients.
    Han K; Bies R; Johnson H; Capitano B; Venkataramanan R
    Clin Pharmacokinet; 2011 Mar; 50(3):201-14. PubMed ID: 21294597
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bayesian Population Physiologically-Based Pharmacokinetic (PBPK) Approach for a Physiologically Realistic Characterization of Interindividual Variability in Clinically Relevant Populations.
    Krauss M; Tappe K; Schuppert A; Kuepfer L; Goerlitz L
    PLoS One; 2015; 10(10):e0139423. PubMed ID: 26431198
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.